Document is current
Any future updates will be listed below
-
Authors
Kaniecki, Robert G.
Friedman, Deborah I.
Asher, Divya
Hirman, Joe
Cady, Roger
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02974153 at ClinicalTrials.govDocuments that mention this clinical trial
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures
https://doi.org/10.1007/s00415-024-12809-z
Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine
https://doi.org/10.1007/s40122-023-00525-x
-
Funding
Funding for this research was provided by:
Lundbeck LLC
- License Information
-
More Information
Article History
Received: 23 February 2023
Accepted: 11 May 2023
First Online: 28 June 2023
